Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antibody Actions01:26

Antibody Actions

1.6K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
1.6K
Cross-reactivity00:42

Cross-reactivity

31.8K
Overview
31.8K
Humoral Immune Responses01:36

Humoral Immune Responses

78.9K
Overview
78.9K
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

1.2K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
1.2K
Affinity and Avidity01:41

Affinity and Avidity

37.1K
Overview
37.1K
Antibody Structure01:10

Antibody Structure

62.1K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
62.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fast Generation of F(Ab')<sub>2</sub> Fragments From Human IgG Using Fc-Fused IgG-Degrading Enzyme.

European journal of immunology·2026
Same author

Shaping T cell responses to factor VIII in hemophilia A with sialylated immunodominant peptides.

Haematologica·2026
Same author

Impact of heme on the therapeutic efficacy of anti-CD20 antibodies.

The Journal of biological chemistry·2026
Same author

Intracellular complement Factor H promotes tumor progression through modulation of cell cycle and actin cytoskeleton.

Communications biology·2026
Same author

Novel assays to assess the prevalence and neutralizing potential of anti-IdeS antibodies in healthy humans.

Frontiers in immunology·2026
Same author

Antibody Polyreactivity: A Challenger of Immune Paradigms.

Immunology·2025

Related Experiment Video

Updated: Oct 29, 2025

Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies
07:55

Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies

Published on: August 29, 2017

11.9K

How can polyreactive antibodies conquer rapidly evolving viruses?

Alejandra Reyes-Ruiz1, Jordan D Dimitrov1

  • 1Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université de Paris, 75006 Paris, France.

Trends in Immunology
|July 11, 2021
PubMed
Summary
This summary is machine-generated.

Antibody polyreactivity helps neutralize rapidly evolving viruses like HIV-1 by tolerating variants and speeding up the immune response. This promiscuous binding is key for effective viral neutralization.

Keywords:
HIV-1antibodiesbroadly neutralizing antibodiesinfluenza viruspolyreactivityviruses

More Related Videos

A Method to Assess Fc-mediated Effector Functions Induced by Influenza Hemagglutinin Specific Antibodies
04:47

A Method to Assess Fc-mediated Effector Functions Induced by Influenza Hemagglutinin Specific Antibodies

Published on: February 23, 2018

7.9K
Engineering Antiviral Agents via Surface Plasmon Resonance
13:00

Engineering Antiviral Agents via Surface Plasmon Resonance

Published on: June 14, 2022

2.5K

Related Experiment Videos

Last Updated: Oct 29, 2025

Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies
07:55

Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies

Published on: August 29, 2017

11.9K
A Method to Assess Fc-mediated Effector Functions Induced by Influenza Hemagglutinin Specific Antibodies
04:47

A Method to Assess Fc-mediated Effector Functions Induced by Influenza Hemagglutinin Specific Antibodies

Published on: February 23, 2018

7.9K
Engineering Antiviral Agents via Surface Plasmon Resonance
13:00

Engineering Antiviral Agents via Surface Plasmon Resonance

Published on: June 14, 2022

2.5K

Area of Science:

  • Immunology
  • Virology
  • Molecular Biology

Background:

  • Rapidly evolving viruses, such as Human Immunodeficiency Virus type 1 (HIV-1) and influenza virus, present significant challenges for vaccine development and treatment due to their high mutation rates.
  • Broadly neutralizing antibodies (bNAbs) are crucial for controlling these viruses, but their development is often hindered by viral evolution.
  • Antigen-binding promiscuity, the ability of an antibody to bind to multiple antigens, is a characteristic observed in some bNAbs.

Purpose of the Study:

  • To investigate the role and significance of antibody polyreactivity in the neutralization of rapidly evolving viruses.
  • To hypothesize how antibody polyreactivity contributes to the immune response against viruses like HIV-1 and influenza.
  • To explore the potential of polyreactivity in overcoming viral evasion mechanisms.

Main Methods:

  • The study is based on recent research findings and proposes a hypothesis.
  • It involves analyzing the characteristics of broadly neutralizing antibodies against rapidly evolving viruses.
  • The hypothesis focuses on the functional implications of antibody polyreactivity.

Main Results:

  • Antibody polyreactivity is hypothesized to be significant in the neutralization of rapidly evolving viruses.
  • Polyreactivity may contribute to the antibody's ability to tolerate viral variants.
  • This characteristic is proposed to shorten the time required for generating effective neutralizing antibodies.

Conclusions:

  • Antibody polyreactivity plays a crucial role in the immune defense against rapidly evolving viruses.
  • Polyreactivity enhances the ability of antibodies to adapt to viral mutations and variants.
  • Targeting or understanding polyreactivity could be a strategy for developing more effective vaccines and therapies against viruses like HIV-1 and influenza.